GlassScriptPhysician profile
Ronald Grand
NPI 1952390460
$4,662.20
in general payments reported to CMS, 2019-2025
17 companies · $586 in 2025
The $586 reported for 2025 was more than what 81% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $815 · 2020: $118 · 2021: $682 · 2022: $809 · 2023: $683 · 2024: $968 · 2025: $586.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,051 · Entertainment: $186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,050.88 |
| Entertainment | $186.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $940.65 | 2023-2025 | Infuse, Miebo, Xiidra |
| Alcon Vision LLC | $627.30 | 2020-2025 | Dailies Total1, Total30, Precision 1 |
| Coopervision INC. | $595.63 | 2019-2025 | Myday Contact Lens, Misight Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $566.68 | 2019-2021 | |
| Eyevance Pharmaceuticals LLC | $359.61 | 2021 | |
| Oyster Point Pharma, INC. | $311.42 | 2022-2024 | Tyrvaya |
| Optos, INC. | $291.76 | 2019-2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Regeneron Healthcare Solutions, INC. | $240.12 | 2019-2022 | |
| Lkc Technologies, INC. | $216.47 | 2024-2025 | |
| Sun Pharmaceutical Industries INC. | $110.50 | 2020-2022 | |
| Glaukos Corporation | $105.99 | 2023 | |
| Optovue, INC. | $104.72 | 2021 | |
| Johnson & Johnson Vision Care, INC. | $81.59 | 2020-2023 | Acuvue |
| Novartis Pharmaceuticals Corporation | $41.82 | 2020-2022 | |
| Dompe US, INC. | $27.36 | 2025 | Oxervate |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $23.81 | 2022 | |
| Shire North American Group INC | $16.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Grand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.